Hygromycin B binds cellular ribosomes and disrupts accurate protein synthesis, producing translation errors and inhibiting growth. Cells carrying the hygromycin-resistance gene can survive because an enzyme inactivates the antibiotic. This differential response converts the medium into a selection environment that enriches for cells with the intended genetic trait.
Enzymatic inactivation gives resistant cells a way to withstand continued exposure, whereas susceptible cells remain affected by the ribosome-targeted antibiotic. As selection continues, the culture becomes enriched for cells retaining a functional resistance gene. This is important when researchers need a stable engineered population rather than a temporary mixture of modified and unmodified cells.
The distinction depends on whether cells acquired and express the hygromycin-resistance gene. Cells lacking that trait remain vulnerable to disrupted translation and inhibited growth, while resistant cells persist through antibiotic inactivation. Consequently, survival under selection provides a practical indication that the engineered population contains cells with the intended resistance mechanism.
After cells acquire the relevant hygromycin-resistance gene, they are cultured in hygromycin-supplemented medium to apply selection. Susceptible cells are inhibited, while resistant cells persist and form the selected population. Researchers can then maintain that population with consistent selection when establishing stable engineered immune or host-cell lines for longer experiments.
These selected lines support studies of gene function, immune signaling, and host-pathogen interactions. Because the cells carry a resistance-based selection trait, researchers can maintain engineered populations while examining how altered genes or cellular pathways influence immune responses and infection-related mechanisms. The approach therefore connects cell engineering with reproducible experimental models in immunology and infection research.
Consistent selection helps preserve the intended engineered cell population during extended studies, reducing variation caused by loss of resistant cells or persistence of susceptible cells. This improves experimental reproducibility when researchers repeatedly measure cellular responses, immune signaling, or host-pathogen interactions. Stable selected populations are especially useful when experiments examine mechanisms over longer periods.